B
Bill Sloman
Guest
Today's issue of the Proceedings of the (US) National Academy of Sciences
starts with an article about potential vaccines against Covid-19
https://www.pnas.org/content/117/15/8218?etoc
It covers some points that have been discussed - rather less coherently - here.
One interesting point, which I hadn't seen before, deals with the prospect of minor tinkering with a vaccine that was being developed against the SARS virus until SARS stopped being enough of a threat to keep the money coming, and should be easily adaptable to the - very similar - active end of the Covid-19 spike protein.
--
Bill Sloman, Sydney
starts with an article about potential vaccines against Covid-19
https://www.pnas.org/content/117/15/8218?etoc
It covers some points that have been discussed - rather less coherently - here.
One interesting point, which I hadn't seen before, deals with the prospect of minor tinkering with a vaccine that was being developed against the SARS virus until SARS stopped being enough of a threat to keep the money coming, and should be easily adaptable to the - very similar - active end of the Covid-19 spike protein.
--
Bill Sloman, Sydney